Aptinyx Inc reported $5.68M in Current Liabilities for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 117.68M 1.92M
Acorda Therapeutics ACOR:US $ 41.12M 4.88M
Biogen BIIB:US $ 5018M 1071.4M
Cara Therapeutics CARA:US $ 21.17M 2.87M
Daiichi Sankyo 4568:JP Y 406816M 11548M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Halozyme Therapeutics HALO:US $ 199.51M 87.82M
Intra Cellular Therapies ITCI:US $ 70.63M 11.56M
IONIS PHARMACEUT IONS:US $ 267.81M 39.36M
Marinus Pharmaceuticals MRNS:US $ 23.11M 3.57M
Neurocrine Biosciences NBIX:US $ 285.7M 32.2M
Novartis NOVN:VX SF 27646M 2161M
Ultragenyx Pharmaceutical RARE:US $ 220.64M 53.4M
Vertex Pharmaceuticals VRTX:US $ 2556.2M 376M